α-Glucosidase-IN-124
α-Glucosidase-IN-124 is an α-glucosidase inhibitor with an IC50 of 18.55 μM. α-Glucosidase-IN-124 also exhibits inhibitory activity against α-amylase. α-Glucosidase-IN-124 delays carbohydrate digestion and reduces postprandial hyperglycemia by inhibiting α-glucosidase and α-amylase. α-Glucosidase-IN-124 can be used in diabetes-related research.
For research use only. We do not sell to patients.
- Formula: C24H16Cl3N5OS
- Molecular Weight:528.84
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
α‑glucosidase 18.55 μM (IC50) |
α-amylase 54.08 μM (IC50) |
In Vitro
α-Glucosidase-IN-124 (Compound 7e) inhibits human lysosomal acid α-glucosidase (HLAG) with an IC50 of 18.55 μM and inhibits human pancreatic α-amylase (HPA) with an IC50 of 54.08 μM[1].
α-Glucosidase-IN-124 forms stable interactions with the key residues ASP645, ASP518, ASP404, and TRP613 in the active site of α-glucosidase, with a docking score of -5.303[1].
α-Glucosidase-IN-124 maintains a consistent binding orientation within the α-glucosidase active site throughout the entire 100 ns simulation and is stabilized by persistent hydrophobic contacts, hydrogen bonds, and water bridges[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
Chemical Information
-
Molecular Weight 528.84
-
Formula C24H16Cl3N5OS
-
SMILES
S=C(N/N=C/C1=CC=C(C=C1)OC2=CC=NC3=CC(Cl)=CC=C32)N/N=C/C4=C(Cl)C(Cl)=CC=C4
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Research Protocol for Metabolic Diseases
AMP-activated protein kinase, AMPK, is a conserved cellular energy sensor that responds to reduced cellular energy status and coordinates metabolism by increasing ATP-generating catabolic pathways while suppressing ATP-consuming anabolic processes. In metabolic disease research, the AMPK pathway is experimentally relevant because it regulates hepatic lipid synthesis, fatty acid oxidation, glucose production, skeletal-muscle glucose disposal, mTORC1-linked biosynthesis, autophagy, mitochondrial homeostasis, and whole-body energy balance. The central pathway logic is that energy stress, metformin, exercise-like stimulation, or direct AMPK activators increase AMPKα Thr172 phosphorylation and downstream substrate phosphorylation, including ACC and RAPTOR. Phosphorylation of ACC suppresses lipogenesis and supports fatty acid oxidation, whereas phosphorylation of RAPTOR suppresses mTORC1 signaling and links cellular energy status to growth and protein synthesis control. The pathway is linked
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)